- Bernaitis L1*, Devadharshini E2, Sasmitha T2, Pranavika A K2, Kalaivani K T2, Jaisharaba A2
- Associate professor, Department of Microbiology, Nandha Siddha Medical College and Hospital, Erode-638052.
- 5-7
Abstract: Candida species are significant human pathogens responsible for various infections, particularly in immunocompromised individuals. The rise of antifungal resistance among these species poses serious challenges for treatment, complicating patient management and leading to increased morbidity and mortality. This review explores the mechanisms of antifungal resistance in Candida, including intrinsic and acquired resistance mechanisms, biofilm formation, and metabolic adaptations. Furthermore, we discuss the current challenges in managing antifungal resistance, including epidemiological trends, clinical implications, and limitations of existing antifungal agents. We also highlight future directions in research and therapeutic development, focusing on novel antifungal agents, combination therapies, and innovative approaches targeting biofilm-associated resistance. Understanding these mechanisms and challenges is essential for developing effective strategies to combat antifungal resistance and improve patient outcomes.
Keywords: Candida, Antifungal resistance, Biofilm formation, Intrinsic resistance, Acquired resistance, Therapeutic development.